Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 49 to 55 of 55 entries
Sorted by: Best Match Show Resources per page
Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators.

Journal of the American College of Cardiology

Jost S, Deckers JW, Nikutta P, Rafflenbeul W, Wiese B, Hecker H, Lippolt P, Lichtlen PR.
PMID: 8473639
J Am Coll Cardiol. 1993 May;21(6):1339-46. doi: 10.1016/0735-1097(93)90306-l.
Free Article

OBJECTIVES: This study represents the first prospective, quantitative analysis of the association of progression of coronary atherosclerosis with anatomic site and diameter.BACKGROUND: The progressive course of coronary artery disease has been documented in many angiographic follow-up trials.METHODS: The data...

Cite
Jost S, Deckers JW, Nikutta P, et al. Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators. J Am Coll Cardiol. 1993;21(6):1339-46doi: 10.1016/0735-1097(93)90306-l.
Jost, S., Deckers, J. W., Nikutta, P., Rafflenbeul, W., Wiese, B., Hecker, H., Lippolt, P., & Lichtlen, P. R. (1993). Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators. Journal of the American College of Cardiology, 21(6), 1339-46. https://doi.org/10.1016/0735-1097(93)90306-l
Jost, S, et al. "Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators." Journal of the American College of Cardiology vol. 21,6 (1993): 1339-46. doi: https://doi.org/10.1016/0735-1097(93)90306-l
Jost S, Deckers JW, Nikutta P, Rafflenbeul W, Wiese B, Hecker H, Lippolt P, Lichtlen PR. Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators. J Am Coll Cardiol. 1993 May;21(6):1339-46. doi: 10.1016/0735-1097(93)90306-l. PMID: 8473639.
Copy Download .nbib Format: NLM
Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.

BMC cardiovascular disorders

Bundhun PK, Yanamala CM, Huang F.
PMID: 27912739
BMC Cardiovasc Disord. 2016 Dec 03;16(1):249. doi: 10.1186/s12872-016-0427-8.

BACKGROUND: Recently published randomized controlled trials have shown different results compared to the Fraction Flow Reserve Versus Angiography for Multi-vessel Evaluation (FAME) study. Therefore, this current analysis aimed to compare the adverse clinical outcomes associated with Fraction Flow Reserve...

Cite
Bundhun PK, Yanamala CM, Huang F. Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2016;16(1):249doi: 10.1186/s12872-016-0427-8.
Bundhun, P. K., Yanamala, C. M., & Huang, F. (2016). Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC cardiovascular disorders, 16(1), 249. https://doi.org/10.1186/s12872-016-0427-8
Bundhun, Pravesh Kumar, et al. "Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials." BMC cardiovascular disorders vol. 16,1 (2016): 249. doi: https://doi.org/10.1186/s12872-016-0427-8
Bundhun PK, Yanamala CM, Huang F. Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2016 Dec 03;16(1):249. doi: 10.1186/s12872-016-0427-8. PMID: 27912739; PMCID: PMC5135818.
Copy Download .nbib Format: NLM
Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosis.

Nature reviews. Cardiology

Tang WH, Hazen SL.
PMID: 28094270
Nat Rev Cardiol. 2017 Jan 17;14(2):71-72. doi: 10.1038/nrcardio.2016.216.

No abstract available.

Cite
Tang WH, Hazen SL. Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosis. Nat Rev Cardiol. 2017;14(2):71-72doi: 10.1038/nrcardio.2016.216.
Tang, W. H., & Hazen, S. L. (2017). Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosis. Nature reviews. Cardiology, 14(2), 71-72. https://doi.org/10.1038/nrcardio.2016.216
Tang, W H Wilson, and Hazen, Stanley L. "Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosis." Nature reviews. Cardiology vol. 14,2 (2017): 71-72. doi: https://doi.org/10.1038/nrcardio.2016.216
Tang WH, Hazen SL. Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosis. Nat Rev Cardiol. 2017 Jan 17;14(2):71-72. doi: 10.1038/nrcardio.2016.216. PMID: 28094270; PMCID: PMC5880294.
Copy Download .nbib Format: NLM
Non-invasive fractional flow reserve using computed tomographic angiography: where are we now and where are we going?.

Heart (British Cardiac Society)

Rajani R, Modi B, Ntalas I, Curzen N.
PMID: 28559426
Heart. 2017 Aug;103(15):1216-1222. doi: 10.1136/heartjnl-2016-311029. Epub 2017 May 30.

No abstract available.

Cite
Rajani R, Modi B, Ntalas I, et al. Non-invasive fractional flow reserve using computed tomographic angiography: where are we now and where are we going?. Heart. 2017;103(15):1216-1222doi: 10.1136/heartjnl-2016-311029.
Rajani, R., Modi, B., Ntalas, I., & Curzen, N. (2017). Non-invasive fractional flow reserve using computed tomographic angiography: where are we now and where are we going?. Heart (British Cardiac Society), 103(15), 1216-1222. https://doi.org/10.1136/heartjnl-2016-311029
Rajani, Ronak, et al. "Non-invasive fractional flow reserve using computed tomographic angiography: where are we now and where are we going?." Heart (British Cardiac Society) vol. 103,15 (2017): 1216-1222. doi: https://doi.org/10.1136/heartjnl-2016-311029
Rajani R, Modi B, Ntalas I, Curzen N. Non-invasive fractional flow reserve using computed tomographic angiography: where are we now and where are we going?. Heart. 2017 Aug;103(15):1216-1222. doi: 10.1136/heartjnl-2016-311029. Epub 2017 May 30. PMID: 28559426.
Copy Download .nbib Format: NLM
Recognizing excellence in coronary artery disease: the Sobel Distinguished Scholarship Award.

Coronary artery disease

Dauerman HL.
PMID: 29394185
Coron Artery Dis. 2018 Mar;29(2):92-94. doi: 10.1097/MCA.0000000000000591.

No abstract available.

Cite
Dauerman HL. Recognizing excellence in coronary artery disease: the Sobel Distinguished Scholarship Award. Coron Artery Dis. 2018;29(2):92-94doi: 10.1097/MCA.0000000000000591.
Dauerman, H. L. (2018). Recognizing excellence in coronary artery disease: the Sobel Distinguished Scholarship Award. Coronary artery disease, 29(2), 92-94. https://doi.org/10.1097/MCA.0000000000000591
Dauerman, Harold L. "Recognizing excellence in coronary artery disease: the Sobel Distinguished Scholarship Award." Coronary artery disease vol. 29,2 (2018): 92-94. doi: https://doi.org/10.1097/MCA.0000000000000591
Dauerman HL. Recognizing excellence in coronary artery disease: the Sobel Distinguished Scholarship Award. Coron Artery Dis. 2018 Mar;29(2):92-94. doi: 10.1097/MCA.0000000000000591. PMID: 29394185.
Copy Download .nbib Format: NLM
Patient information. What is a nuclear cardiac stress test?.

JAAPA : official journal of the American Academy of Physician Assistants

[No authors listed]
PMID: 19248363
JAAPA. 2009 Jan;22(1):56.

No abstract available.

Cite
Patient information. What is a nuclear cardiac stress test?. JAAPA. 2009;22(1):56
(2009). Patient information. What is a nuclear cardiac stress test?. JAAPA : official journal of the American Academy of Physician Assistants, 22(1), 56.
"Patient information. What is a nuclear cardiac stress test?." JAAPA : official journal of the American Academy of Physician Assistants vol. 22,1 (2009): 56.
Patient information. What is a nuclear cardiac stress test?. JAAPA. 2009 Jan;22(1):56. PMID: 19248363.
Copy Download .nbib Format: NLM
Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance.

The American journal of medicine

Li DL, Kronenberg MW.
PMID: 33864764
Am J Med. 2021 Aug;134(8):968-975. doi: 10.1016/j.amjmed.2021.03.011. Epub 2021 Apr 20.

Coronary artery disease is a leading cause of morbidity and mortality worldwide. Noninvasive imaging tests play a significant role in diagnosing coronary artery disease, as well as risk stratification and guidance for revascularization. Myocardial perfusion imaging, including single photon...

Cite
Li DL, Kronenberg MW. Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance. Am J Med. 2021;134(8):968-975doi: 10.1016/j.amjmed.2021.03.011.
Li, D. L., & Kronenberg, M. W. (2021). Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance. The American journal of medicine, 134(8), 968-975. https://doi.org/10.1016/j.amjmed.2021.03.011
Li, Dan L, and Kronenberg, Marvin W. "Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance." The American journal of medicine vol. 134,8 (2021): 968-975. doi: https://doi.org/10.1016/j.amjmed.2021.03.011
Li DL, Kronenberg MW. Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance. Am J Med. 2021 Aug;134(8):968-975. doi: 10.1016/j.amjmed.2021.03.011. Epub 2021 Apr 20. PMID: 33864764.
Copy Download .nbib Format: NLM
Showing 49 to 55 of 55 entries